Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose versus placebo in congestive heart failure
2012-001134-33Phase 3Terminated
- Sponsor
- University Hospital Ulm
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Ferric carboxymaltose with Placebo (2 arms). Primary endpoint: Change in left-ventricular ejection fraction by cardiac MRI. Started Aug 2012; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2012-001134-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001134-33.